news

Access Accelerated in Action shares experiences from 19 member company NCD access programs implemented in collaboration with more than 50 cross-sector partners

GENEVA, SWITZERLAND – 20 May 2019 – Today, at a side event on the margins of the 72nd World Health Assembly, Access Accelerated, a global partnership of more than 20 biopharmaceutical companies, launched Access Accelerated in Action: Key Learnings in Program Design & Implementation. This resource is the first collective effort from Access Accelerated member companies to share insights from their NCD programs in low- and middle-income countries (LMICs). Access Accelerated in Action is an effort to enhance the impact of public-private partnerships to address the global NCD burden and strengthen health systems in support of Universal Health Coverage (UHC). Read More

Two global biopharmaceutical companies join effort to address the growing non-communicable disease burden in low- and middle-income countries

GENEVA, SWITZERLAND – Today, Ipsen and Servier, two global biopharmaceutical companies, joined Access Accelerated, an initiative aimed at advancing access to non-communicable disease (NCD) prevention, treatment and care in low- and middle income countries (LMICs). Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases.Read More

press releases

Access Accelerated Launches New Resource to Share Learnings in Non-Communicable Disease (NCD) Program Design

Access Accelerated in Action shares experiences from 19 member company NCD access programs implemented in collaboration with more than 50 cross-sector partners

Access Accelerated in Action

Access Accelerated is a unique cross-industry collaboration that seeks to reduce barriers to prevention, treatment, and care for non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) through health systems strengthening and alignment with UHC objectives and priorities.

Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Grant Program Will Help Fund Cancer Care Capability, Delivery and Access Programs 

SUMMIT, NJ, December 5, 2017 – Celgene Corporation (NASDAQ:CELG) today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world. As part of this program, Celgene will collaborate with medical centers focused on enhancing patient care and building sustainable cancer care systems in resourceconstrained countries. Funding will be provided to approved programs in 2018.
Read More

newsletters

Access Accelerated returned to Kenya on 28 February and 1 March for the non-communicable diseases (NCD) stakeholder meeting, “Redefining UHC – the Opportunity for NCDs,” cohosted with the Ministry of Health and NCD Alliance Kenya in Naivasha, Kenya.

With representation from the Kenyan government across ministries and attendees that spanned civil society, representatives from 12 Access Accelerated member companies, people living with NCDs (PLWNCDs) and government officials from six African nations, the meeting provided a forum to reflect on progress made and recommit to increasing access to NCD treatment and care in the context of the country’s push toward Universal Health Coverage (UHC).Read More

Videos

Possibilities

We believe a life not defined by disease is a life of possibility.